BOCA RATON, FL, May 21 /PRNewswire-FirstCall/ -- Former SEC Attorney Carl N. Duncan has been engaged as outside Traxxec Inc. general counsel. In addition to representing Traxxec Inc. in its corporate and securities activities, Mr. Duncan will also work closely over the next 60 days with the company's auditors Hilson Financial Services Inc., Boyton Beach Florida to ensure a successful move to reporting status and listing on a higher stock board. Mr. Duncan brings to Traxxec Inc (OTC:TRXX.PK) over 30 years legal experience, including serving as Attorney-Advisor in the Division of Corporate Finance and Senior Attorney in the Office of Tender Offers, Acquisitions and Small Issues, both in the U.S. Securities and Exchange Commission. In addition, Duncan represents a substantial number of issuers in (and underwriters of) private and/or public offerings in various industries in not less than 15 countries and as many as 48 states. Gloria McConnell, President of Traxxec Inc., stated, "We are delighted that Carl has chosen to represent Traxxec Inc. and Stem Cell Assurance, leading the progression of the company from the legal and reporting aspect. He brings both extensive knowledge about corporate reporting and actions and experience of taking and maintaining reporting companies at the higher levels. This is a significant move by the Board, one that will help Traxxec Inc. and Stem Cell Assurance's management to continue to grow successfully." See http://www.stemcellassurance.com/ for more information. Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements. DATASOURCE: Traxxec Inc. CONTACT: Investor Relations: George Dubec, (561) 362-4142, Stem Cell Assurance, http://www.stemcellassurance.com/,

Copyright